Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 23629998)

1.

Telangiectatic osteosarcoma.

Colomina J, Peiro A, Trullols L, Garcia I.

J Orthop Surg (Hong Kong). 2013 Apr;21(1):96-9.

2.

Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.

Scully SP, Ghert MA, Zurakowski D, Thompson RC, Gebhardt MC.

J Bone Joint Surg Am. 2002 Jan;84-A(1):49-57. Erratum in: J Bone Joint Surg Am 2002 Apr;84-A(4):622.

PMID:
11792779
3.

Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.

Xie L, Guo W, Li Y, Ji T, Sun X.

J Surg Oncol. 2012 Dec;106(7):820-5. doi: 10.1002/jso.23150. Epub 2012 Jun 27.

PMID:
22740310
4.

Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.

Zuo D, Zheng L, Sun W, Hua Y, Cai Z.

World J Surg Oncol. 2013 Jun 24;11:148. doi: 10.1186/1477-7819-11-148.

5.

The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture.

Scully SP, Temple HT, O'Keefe RJ, Mankin HJ, Gebhardt M.

Clin Orthop Relat Res. 1996 Mar;(324):227-32.

PMID:
8595761
6.

Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.

Bacci G, Ferrari S, Longhi A, Donati D, Manfrini M, Giacomini S, Briccoli A, Forni C, Galletti S.

Acta Orthop Scand. 2003 Aug;74(4):449-54.

PMID:
14521297
7.

Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma.

Ferguson PC, McLaughlin CE, Griffin AM, Bell RS, Deheshi BM, Wunder JS.

J Surg Oncol. 2010 Aug 1;102(2):120-4. doi: 10.1002/jso.21542.

PMID:
20648581
8.

Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.

Weiss A, Khoury JD, Hoffer FA, Wu J, Billups CA, Heck RK, Quintana J, Poe D, Rao BN, Daw NC.

Cancer. 2007 Apr 15;109(8):1627-37.

9.

[The surgical treatment and outcome of nonmetastatic osteosarcoma of the extremity with pathologic fractures].

Niu XH, Ding Y.

Zhonghua Wai Ke Za Zhi. 2008 Nov 15;46(22):1730-3. Chinese.

PMID:
19094736
10.

Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.

Jaffe N, Spears R, Eftekhari F, Robertson R, Cangir A, Takaue Y, Carrasco H, Wallace S, Ayala A, Raymond K, et al.

Cancer. 1987 Feb 15;59(4):701-9.

PMID:
3492261
11.

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G; Italian and Scandinavian Sarcoma Groups.

J Clin Oncol. 2005 Dec 1;23(34):8845-52. Epub 2005 Oct 24.

12.

[Telangiectatic osteosarcoma: report of 10 cases].

Zhang Q, Cai Y, Niu X, Hao L, Ding Y, Yu F.

Zhonghua Wai Ke Za Zhi. 2000 Dec;38(12):903-5, 50. Chinese.

PMID:
11832192
13.

[Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].

Zhang Q, Niu XH, Cai YB, Hao L, Ding Y.

Zhonghua Wai Ke Za Zhi. 2007 Aug 15;45(16):1114-7. Chinese.

PMID:
18005614
14.

Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.

Bacci G, Ferrari S, Mercuri M, Bertoni F, Picci P, Manfrini M, Gasbarrini A, Forni C, Cesari M, Campanacci M.

Acta Orthop Scand. 1998 Jun;69(3):230-6.

PMID:
9703394
15.

Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).

Rodriguez-Galindo C, Shah N, McCarville MB, Billups CA, Neel MN, Rao BN, Daw NC.

Cancer. 2004 May 1;100(9):1928-35.

16.

Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy.

Pignatti G, Bacci G, Picci P, Dallari D, Bertoni F, Bacchini P, Capanna R.

Clin Orthop Relat Res. 1991 Sep;(270):99-106.

PMID:
1884565
17.

Surgical outcomes in osteosarcoma.

Grimer RJ, Taminiau AM, Cannon SR; Surgical Subcommitte of the European Osteosarcoma Intergroup.

J Bone Joint Surg Br. 2002 Apr;84(3):395-400.

18.

The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours.

Moradi B, Zahlten-Hinguranage A, Lehner B, Zeifang F.

Int Orthop. 2010 Oct;34(7):1017-23. doi: 10.1007/s00264-009-0921-z. Epub 2009 Dec 13.

19.

Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.

Bacci G, Ferrari S, Mercuri M, Longhi A, Fabbri N, Galletti S, Forni C, Balladelli A, Serra M, Picci P.

Acta Orthop. 2007 Jun;78(3):377-84.

PMID:
17611853
20.

Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? : a systematic review and meta-analysis.

Salunke AA, Chen Y, Tan JH, Chen X, Khin LW, Puhaindran ME.

Bone Joint J. 2014 Oct;96-B(10):1396-403. doi: 10.1302/0301-620X.96B10.34370. Review.

PMID:
25274928
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk